Rapid development of vein graft atheroma in apoE-deficient mice

American Journal of Pathology

Volumn 157, Issue 2, 2000, Pages 659-669

  Dietrich, Hermann ^a   Hu, Yanhua ^a   Zou, Yiping ^b   Huemer, Ursula ^a   Metzler, Bernhard ^c   Li, Chaohong ^b   Mayr, Manuel ^b   Xu, Qingbo ^b  

^a MEDICAL UNIVERSITY OF INNSBRUCK   (Austria)

^b ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ATHEROMA; CELL DEATH; CELL INFILTRATION; DISEASE MODEL; FOAM CELL; HISTOPATHOLOGY; HYPERCHOLESTEROLEMIA; INTIMA; MONONUCLEAR CELL; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; VEIN GRAFT;

EID: 0033889232     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64576-2     Document Type: Article

References (42)

1. Syndromes of accelerated atherosclerosis: Role of vascular injury and smooth muscle cell proliferation
2. Pathobiology of intimal hyperplasia
3. Aortocoronary saphenous vein graft disease: Pathogenesis, predisposition, and prevention
4. Is aggressive cholesterol control justified? Review of the post-coronary artery bypass graft trial
5. Relation of saphenous vein graft obstruction to serum cholesterol levels
6. The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation: A study 10 years after aortocoronary bypass surgery
7. Coronary artery bypass grafting in familial hypercholesterolemia
8. Distention promotes platelet and leukocyte adhesion and reduces short-term patency in pig arteriovenous bypass grafts
9. The integrity of experimental vein graft endothelium: Implications on the etiology of early vein graft failure
10. Histologic, morphometric, and biochemical evaluation of vein bypass grafts in a nonhuman primate model I. Sequential changes within the first three months
11. Intimal hyperplasia in autogenous vein grafts used for arterial bypass: A canine model
12. The influence of nifedipine on microvascular vein graft intimal thickening
13. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E
14. Mouse model of venous bypass graft arteriosclerosis
15. Mouse model of transplant arteriosclerosis: Role of intercellular adhesion molecule-1
16. Biomechanical stress-induced apoptosis in vein grafts involves p38 mitogen-activated protein kinases
17. Promotion of lymphocyte growth by high density lipoproteins (HDL): Physiological significance of the HDL binding site
18. Lipid utilization by human lymphocytes is correlated with high-density-lipoprotein binding site activity
19. Co-expression of ICAM-1, VCAM-1, ELAM-1 and Hsp60 in human arterial venous endothelial cells in response to cytokines and oxidized low density lipoproteins
20. Microsomal lipid peroxidation
21. Reduced neointima hyperplasia of vein bypass grafts in intercellular adhesion molecule-1-deficient mice
22. LDL stimulates mitogen-activated protein kinase phosphatase-1 expression independent of LDL receptors in vascular smooth muscle cells
23. Regional accumulations of T cells, macrophages and smooth muscle cells in the human atherosclerotic plaque
24. Immunology of atherosclerosis: Cellular composition and major histocompatibility complex class II antigen expression in aortic intima, fatty streaks, and atherosclerotic plaques in young and aged human specimens
25. Foam cell replication and smooth muscle cell apoptosis in human saphenous vein grafts
26. Immunocytochemical investigation of atherosclerotic changes observed in aortocoronary bypass vein grafts using monoclonal antibodies
27. Immunocytochemical determination of cell type and proliferation rate in human vein graft stenoses
28. Atherosclerosis in rabbit vein grafts
29. Early morphology of accelerated vein graft atheroma in experimental vein grafts
30. Hypercholesterolemia and experimental vein grafts: Accelerated development of intimal hyperplasia and an increase in abnormal vasomotor function
31. Inhibition of neointima hyperplasia of mouse vein grafts by locally applied suramin
32. Signal transduction in arteriosclerosis: Mechanical stress-activated MAP kinases in vascular smooth muscle cells
33. Acute hypertension activates mitogen-activated protein kinases in arterial wall
34. Activation of mitogen-activated protein kinases (ERK/JNK) and AP-1 transcription factor in rat carotid arteries after balloon injury
35. Activation of PDGF receptor α in vascular smooth muscle cells by mechanical stress
36. Cyclic strain stress-induced mitogen-activated protein kinase (MAPK) phosphatase-1 expression in vascular smooth muscle cells is regulated by ras/rac-MAPK pathways
37. Increased sensitivity of human vascular smooth muscle cells from atherosclerotic plaques to p53-mediated apoptosis
38. Cooperative interactions between RB and p53 regulate cell proliferation, cell senescence, and apoptosis in human vascular smooth muscle cells from atherosclerotic plaques
39. Apoptosis: Molecular aspects of cell death and disease
40. Apoptosis of vascular smooth muscle cells in atherosclerosis
41. A monocyte chemotactic factor, S19 ribosomal protein dimer, in phagocytic clearance of apoptotic cells
42. S19 ribosomal protein cross-linked dimer causes monocyte-predominant infiltration by means of molecular mimicry to complement C5a